SEC Form 4 · accession 0000880771-15-000108
SCICLONE PHARMACEUTICALS INC · SCLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wilson Wai-Shun Cheung
Officer — CFO & Senior VP, Finance
Period of report
Aug 13, 2015
Accepted (ET)
Aug 17, 2015 · 12:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 13, 2015 | M | 12,500 | $0.00 | A | 12,500 | D | |
| Common Stock | Aug 13, 2015 | F | 4,697 | $8.05 | D | 7,803 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2,F3 | — | Aug 13, 2015 | M | 12,500 | D | — | — | Common Stock | 12,500 | 112,000 | D |
Explanation of responses
- F1Shares disposed represent shares withheld to cover withholding tax obligations in connection with the vesting of Restricted Stock Units.
- F2Each restricted stock unit represents the contingent right to receive one share of SciClone Pharmaceuticals, Inc.'s common stock.
- F3Provided Reporting Person remains employed by the Issuer, 25% of the restricted stock units will vest on each July 16, 2014, July 16, 2015, July 16, 2016, and July 16, 2017, unless the trading window is closed for the Reporting Person on such date, in which case the vesting date will be deferred until the next date that the trading window is open.